Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06333925Not ApplicableActive Not Recruiting

Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Role: collaborator

NCT07220941Not ApplicableRecruiting

Digital Intervention for Adults With Misophonia: A Randomized Controlled Trial

Role: collaborator

NCT04348591Not ApplicableCompleted

Identifying the Optimal Neural Target for Misophonia Interventions

Role: collaborator

All 3 trials loaded